Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Invest ; 131(22)2021 11 15.
Article in English | MEDLINE | ID: mdl-34779418

ABSTRACT

Metabolic pathways regulate immune responses and disrupted metabolism leads to immune dysfunction and disease. Coronavirus disease 2019 (COVID-19) is driven by imbalanced immune responses, yet the role of immunometabolism in COVID-19 pathogenesis remains unclear. By investigating 87 patients with confirmed SARS-CoV-2 infection, 6 critically ill non-COVID-19 patients, and 47 uninfected controls, we found an immunometabolic dysregulation in patients with progressed COVID-19. Specifically, T cells, monocytes, and granulocytes exhibited increased mitochondrial mass, yet only T cells accumulated intracellular reactive oxygen species (ROS), were metabolically quiescent, and showed a disrupted mitochondrial architecture. During recovery, T cell ROS decreased to match the uninfected controls. Transcriptionally, T cells from severe/critical COVID-19 patients showed an induction of ROS-responsive genes as well as genes related to mitochondrial function and the basigin network. Basigin (CD147) ligands cyclophilin A and the SARS-CoV-2 spike protein triggered ROS production in T cells in vitro. In line with this, only PCR-positive patients showed increased ROS levels. Dexamethasone treatment resulted in a downregulation of ROS in vitro and T cells from dexamethasone-treated patients exhibited low ROS and basigin levels. This was reflected by changes in the transcriptional landscape. Our findings provide evidence of an immunometabolic dysregulation in COVID-19 that can be mitigated by dexamethasone treatment.


Subject(s)
Basigin/physiology , COVID-19/immunology , Dexamethasone/pharmacology , SARS-CoV-2 , T-Lymphocytes/metabolism , Adult , COVID-19/metabolism , Cyclophilin A/physiology , Fatty Acids/metabolism , Female , Humans , Male , Middle Aged , Mitochondria/pathology , Reactive Oxygen Species/metabolism
2.
J Comput Biol ; 27(3): 342-355, 2020 03.
Article in English | MEDLINE | ID: mdl-31995401

ABSTRACT

The gene expression profile of a tissue averages the expression profiles of all cells in this tissue. Digital tissue deconvolution addresses the following inverse problem: given the expression profile y of a tissue, what is the cellular composition c of that tissue? If X is a matrix whose columns are reference profiles of individual cell types, the composition c can be computed by minimizing ℒ ( y - X c ) for a given loss function ℒ . Current methods use predefined all-purpose loss functions. They successfully quantify the dominating cells of a tissue, while often falling short in detecting small cell populations. In this study we use training data to learn the loss function ℒ along with the composition c . This allows us to adapt to application-specific requirements such as focusing on small cell populations or distinguishing phenotypically similar cell populations. Our method quantifies large cell fractions as accurately as existing methods and significantly improves the detection of small cell populations and the distinction of similar cell types.


Subject(s)
Computational Biology/methods , Melanoma/genetics , Algorithms , Gene Expression , Humans , Loss of Function Mutation , Machine Learning
3.
J Comput Biol ; 27(3): 386-389, 2020 03.
Article in English | MEDLINE | ID: mdl-31995409

ABSTRACT

Digital tissue deconvolution (DTD) estimates the cellular composition of a tissue from its bulk gene-expression profile. For this, DTD approximates the bulk as a mixture of cell-specific expression profiles. Different tissues have different cellular compositions, with cells in different activation states, and embedded in different environments. Consequently, DTD can profit from tailoring the deconvolution model to a specific tissue context. Loss-function learning adapts DTD to a specific tissue context, such as the deconvolution of blood, or a specific type of tumor tissue. We provide software for loss-function learning, for its validation and visualization, and for applying the DTD models to new data.


Subject(s)
Computational Biology/methods , Transcriptome , Humans , Organ Specificity , Sequence Analysis, RNA , Software
4.
Phys Rev Lett ; 125(24): 242002, 2020 Dec 11.
Article in English | MEDLINE | ID: mdl-33412018

ABSTRACT

In this Letter, we provide a determination of the coupling constant in three-flavor quantum chromodynamics (QCD), α_{s}^{MS[over ¯]}(µ), for MS[over ¯] renormalization scales µ∈(1,2) GeV. The computation uses gauge field configuration ensembles with O(a)-improved Wilson-clover fermions generated by the Coordinated Lattice Simulations (CLS) consortium. Our approach is based on current-current correlation functions and has never been applied before in this context. We convert the results perturbatively to the QCD Λ parameter and obtain Λ_{MS[over ¯]}^{N_{f}=3}=342±17 MeV, which agrees with the world average published by the Particle Data Group and has competing precision. The latter was made possible by a unique combination of state-of-the-art CLS ensembles with very fine lattice spacings, further reduction of discretization effects from a dedicated numerical stochastic perturbation theory simulation, combining data from vector and axial-vector channels, and matching to high-order perturbation theory.

SELECTION OF CITATIONS
SEARCH DETAIL
...